Valeant Pharmaceuticals $45.4 Million Fair Fund

If you purchased or acquired Valeant Pharmaceuticals International, Inc. common stock between October 20, 2014, and April 28, 2016, or certain Valeant bonds between October 20, 2014, and October 29, 2015, you may be eligible to claim compensation from an SEC civil action.

Valeant Pharmaceuticals International, Inc., now operating as Bausch Health Companies Inc., must pay $45,425,000 due to allegations of misstating revenue transactions and erroneous revenue allocations.

Who Can File a Claim?

To be eligible for a claim, you must have purchased or acquired Valeant common stock or specific bonds during the designated periods. Here are the details:

• Common Stock: Purchased between October 20, 2014, and April 28, 2016.
• Bonds: Purchased between October 20, 2014, and October 29, 2015. Eligible bonds are listed in Table C of the Plan of Allocation.

Certain individuals and entities are excluded from recovering compensation:

• Employees terminated for cause or who resigned in connection with the conduct described in the Order.
• Individuals subject to criminal charges related to the conduct described in the Order.
• Entities in which the Respondents have or had a controlling interest.
• Purchasers or assignees of another person's right to obtain recovery from the Fair Fund, unless obtained by gift, inheritance, or devise.

How Much is the Distribution per Person?

The distribution payments will be determined according to the Plan of Allocation. The amount each person can receive depends on their Recognized Loss minus any compensation received from other sources, plus any Reasonable Interest awarded.

• Recognized Loss Calculation: The distribution amount will be capped at the Recognized Loss less any prior recovery, plus any Reasonable Interest awarded.
• Minimum Distribution Amount: If an Eligible Claimant’s Pro Rata Percentage is less than $10, they will not receive a distribution.

Hypothetical Example of Distribution Calculation

If a claimant's Recognized Loss is $1,000 and they have received $200 from other sources, the distribution amount would be calculated as follows:

• Recognized Loss: $1,000
• Prior Recovery: $200
• Distribution Amount: $1,000 - $200 = $800 (plus any Reasonable Interest)

Is Proof Required to Submit a Claim?

Yes, claimants need to provide proof of their transactions in Valeant securities. Acceptable supporting documentation includes broker confirmations or equivalent documents.

How to Claim Compensation

To claim compensation, you must submit a completed Claim Form with the necessary documentation by the deadline. You can file a claim online or download the PDF claim form and mail it to the Fund Administrator.

Valeant Pharmaceuticals Fair Fund

c/o KCC Class Action Services

Fund Administrator

P.O. Box 301133

Los Angeles, CA 90030-1133

Claim Instructions

1. Gather all necessary documentation, such as broker confirmations.
2. Complete the Claim Form, ensuring all sections are filled out accurately.
3. Submit the form online or mail it to the provided address.
4. Ensure you receive a confirmation of your submission.

Payment Methods

Payments will be made via check to the eligible claimants.

$45,425,000 Settlement Fund

The settlement fund of $45,425,000 will cover the distribution to harmed investors, administrative costs, and other related expenses. Specific allocations for lead plaintiffs or attorneys' fees are not detailed in the provided information.

Important Dates

• Deadline to File a Claim: January 16, 2025

When is the Valeant Pharmaceuticals Fair Fund Payout Date?

The payout date for the awards has not been determined as of the date of publishing. We will update this page when the information becomes available. You should also monitor the official fund website.

Why Was There a Class Action Settlement?

The class action lawsuit was initiated due to Valeant's alleged misstatements of revenue transactions and erroneous revenue allocations, which were not disclosed in their SEC filings and investor presentations. Valeant was found to have improperly recognized revenue related to Philidor, a mail-order pharmacy, and failed to disclose the impact of significant price increases on certain drugs.

What Happens Next?

Eligible claimants should submit their claims by the deadline to be considered for a distribution. Further updates will be provided on the official settlement website.